Visnadine

This classification denotes a vasodilating agent with the molecular formula C21H24O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0RL4V0K263, chemically known as 3,4,5-trihydroxy-2,2-dimethyl-6-chromanacrylic acid delta-lactone 4-acetate 3-(2-methylbutyrate) but generally known as visnadine, which bears US NIH Compound Identifier 10157. European Medicines Agency schedules Visnadine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00083MIG. The term VISNADINE is an International Non-Proprietary Name. World Health Organization schedules visnadine in its Anatomical Therapeutic Chemical (ATC) Classification. VISNADINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, VISNADINE remains the US FDA Preferred Term for this commodity. Visnadine bears US NLM identifiers UMLS ID C0644519 and NCI Concept Code C87287. SMILES: O1C(C(OC(=O)C(CC)C)C(OC(=O)C)c2c1ccc1c2oc(=O)cc1)(C)C.